혈액암 (AML/ALL) | 바이오모아

ADCBiologicBeijing Biostar Pharmaceuticals…Phase 2

Utidelone (Utidelone)

Non-small Cell Lung Cancer Patients with Brain Metastases · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 36상태 RECRUITING

CGTBiologicBristol Myers Squibbvedotin plus bendamustine a…Phase 2

lisocabtagene maraleucel (JCAR017, JCAR017 (lisocabtagene maraleucel))

Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Small Lymphocytic · Leukemia, Lymphocytic, Chronic, B-Cell

#LeukemiaLymphocyticChronicB-Cell#CGT#Phase2#세포유전치료#CAR-T+5

효능 ORR 80.5%임상시험 34상태 RECRUITING

CGTBiologicBristol Myers Squibbvedotin plus bendamustine a…Phase 2

JCAR017 (JCAR017, JCAR017 (lisocabtagene maraleucel) + ibrutinib, lisocabtagene maraleucel)

Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Small Lymphocytic · Leukemia, Lymphocytic, Chronic, B-Cell

#LeukemiaLymphocyticChronicB-Cell#CGT#Phase2#세포유전치료#CAR-T+5

효능 ORR 80.5%임상시험 34상태 RECRUITING

CGTBiologicBristol Myers Squibbvedotin plus bendamustine a…Phase 2

JCAR017 (JCAR017, JCAR017 (lisocabtagene maraleucel) + venetoclax, lisocabtagene maraleucel)

Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Small Lymphocytic · Leukemia, Lymphocytic, Chronic, B-Cell

#LeukemiaLymphocyticChronicB-Cell#CGT#Phase2#세포유전치료#CAR-T+5

효능 ORR 80.5%임상시험 34상태 RECRUITING

CGTBiologicHe HuangPhase 1

CAR-T cells chimeric antigen receptor T cells (CAR-T cells chimeric antigen receptor T cells)

Relapsed/Refractory Acute Myeloid Leukemia(AML) · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5

효능 0%임상시험 32상태 RECRUITING

CGTBiologicAbbVievedotin (RC48) with the est…Phase 2

Granulocyte Colony-Stimulating Factor (Granulocyte Colony-Stimulating Factor)

AML, Childhood; Aml · AML, Childhood

#AMLChildhood#CGT#Phase2#세포유전치료#CAR-T+5

효능 ORR 20.4%임상시험 32상태 RECRUITING

AntibodyBristol Myers SquibbPhase 2

nivolumab (Opdivo, Ipilimumab plus nivolumab)

Melanoma; Non Small Cell Lung Cancer · Melanoma

#Melanoma#Antibody#Phase2#항체#면역항체+3

효능 ORR 77.8%임상시험 32상태 RECRUITING

ADCBiologicAkesoaxisPhase 3

Platinum chemotherapy (Platinum chemotherapy)

Advanced Non Small Cell Lung Cancer (NSCLC) · Advanced Non Small Cell Lung Cancer (NSC

#AdvancedNonSmallCellLungCancerNS#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 65.1%임상시험 32상태 RECRUITING

AntibodyETOP IBCSG Partners Foundationderuxtecan (Arm 4), followe…Phase 3

durvalumab (Imfinzi, Adjuvant durvalumab)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+4

효능 ORR 45%임상시험 31상태 RECRUITING

CGTBiologicLiaoning Medical Diagnosis and …designPhase 2

Autologous immune Cells (Autologous immune Cells)

Lung Cancer (Locally Advanced or Metastatic); Liver Cancer (Locally Advanced or Metastatic) · Lung Cancer (Locally Advanced or Metasta

#LungCancerLocallyAdvancedorMetas#CGT#Phase2#세포유전치료#CAR-T+5

임상시험 31상태 RECRUITING

AntibodyMerck Sharp & Dohme LLCADCsPhase 3

H1 receptor antagonist (H1 receptor antagonist)

Ovarian Cancer; Fallopian Tube Cancer · Lung Neoplasm Malignant

#LungNeoplasmMalignant#Antibody#Phase3#항체#면역항체+5

효능 ORR 6%임상시험 31상태 RECRUITING

AntibodyMerck Sharp & Dohme LLCPhase 3

H2 receptor antagonist (H2 receptor antagonist)

Ovarian Cancer; Fallopian Tube Cancer · Lung Neoplasm Malignant

#LungNeoplasmMalignant#Antibody#Phase3#항체#면역항체+4

임상시험 31상태 RECRUITING

ADCBiologicstaleOHSU Knight Cancer InstitutePhase 1

Losartan (Losartan)

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Anatomic Stage IV Breast Cancer AJCC v8 · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4

임상시험 31상태 DISCONTINUED

CGTBiologicSyndax Pharmaceuticalscalicheamicin linked to ant…Phase 3

Midostaurin (Midostaurin)

Acute Myeloid Leukemia; Myelodysplastic Syndrome · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase3#세포유전치료#CAR-T+5

효능 ORR 59.6%임상시험 31상태 RECRUITING

ADCBiologicstaleMing-Yuan ChenPhase 3

Neoadjuvant and Adjuvant Immunotherapy (Neoadjuvant and Adjuvant Immunotherapy)

Locally Advanced Head and Neck Squamous Cell Carcinoma · Locally Advanced Head and Neck Squamous

#LocallyAdvancedHeadandNeckSquamo#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 10%임상시험 31상태 RECRUITING

ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

Neurokinin-1 receptor antagonist (Neurokinin-1 receptor antagonist)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 31상태 RECRUITING

AntibodystaleBristol Myers SquibbPhase 2

nivolumab (Opdivo, Nivolumab starting at day -1)

B Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia, in Relapse · B Acute Lymphoblastic Leukemia

#BAcuteLymphoblasticLeukemia#Antibody#Phase2#항체#면역항체+4

효능 ORR 25%임상시험 31상태 RECRUITING

ADCBiologicstaleInstitut Claudius RegaudApproved

Pharmacokinetics blood samples (Pharmacokinetics blood samples)

Locally Advanced or Metastatic Breast Cancers · Locally Advanced or Metastatic Breast Ca

#LocallyAdvancedorMetastaticBreas#ADC#Approved#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 91.2%임상시험 31상태 RECRUITING

ADCBiologicstaleBellicum PharmaceuticalsPhase 2

Rimiducid (Rimiducid)

Acute Lymphoblastic Leukemia; Leukemia, Acute Myeloid (AML), Child · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4

임상시험 31상태 RECRUITING

CGTBiologicstaleWuhan Sian Medical Technology C…Phase 2

Second generation CAR-T cells (Second generation CAR-T cells)

Acute Lymphoblastic Leukemia; B Cell Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 31상태 ACTIVE

8 / 43 페이지

← 이전 다음 →

갱신 기록 없음 · 14일 주기 · 방문 0 / 568